Advances in the treatment of Adamantinomatous craniopharyngioma: How to balance tumor control and quality of life in the current environment: a narrative review

A Chen, MD Ai, T Sun - Frontiers in Oncology, 2023 - frontiersin.org
Adamantinomatous craniopharyngioma (ACP) presents a significant challenge to
neurosurgeons despite its benign histology due to its aggressive behavior and unique …

Multi-modality management of craniopharyngioma: a review of various treatments and their outcomes

J Varlotto, C DiMaio, C Grassberger… - Neuro-oncology …, 2016 - academic.oup.com
Craniopharyngioma is a rare tumor that is expected to occur in∼ 400 patients/year in the
United States. While surgical resection is considered to be the primary treatment when a …

Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a Pediatric Brain Tumor Consortium report

S Goldman, IF Pollack, RI Jakacki, CA Billups… - Neuro …, 2020 - academic.oup.com
Background Craniopharyngiomas account for approximately 1.2–4% of all CNS tumors.
They are typically treated with a combination of surgical resection and focal radiotherapy …

Treatment of cystic craniopharyngioma with phosphorus-32 intracavitary irradiation

R Zhao, J Deng, X Liang, J Zeng, X Chen… - Child's nervous system, 2010 - Springer
Purpose The aim of the study was to evaluate the effect of phosphorus-32 colloid ([32 P])
intracavitary irradiation on the treatment of patients with cystic craniopharyngiomas. Methods …

Production and clinical applications of radiopharmaceuticals and medical radioisotopes in Iran

AR Jalilian, D Beiki, A Hassanzadeh-Rad… - Seminars in Nuclear …, 2016 - Elsevier
During past 3 decades, nuclear medicine has flourished as vibrant and independent
medical specialty in Iran. Since that time, more than 200 nuclear physicians have been …

Intracystic irradiation for craniopharyngiomas

JV Julow - Pituitary, 2013 - Springer
Data collected over a 36-year period were used to assess the value of stereotactically
applied intracystic colloidal yttrium-90 (YTx) for the treatment of recurrent cystic …

Patient-specific dosimetry for intracavitary 32P-chromic phosphate colloid therapy of cystic brain tumours

AM Denis-Bacelar, M Romanchikova… - European journal of …, 2013 - Springer
Purpose 32 P-chromic phosphate colloid treatments of astrocytoma and craniopharyngioma
cystic brain tumours in paediatric patients are conventionally based on a sphere model …

Evaluation of Bremsstrahlung radiation dose in stereotactically radiocolloid therapy of cystic craniopharyngioma tumors with 32P radio-colloid

M Babaei, R Ghahramani-Asl, HR Sadoughi… - Australasian physical & …, 2018 - Springer
Over 90% of craniopharyngeal brain tumors are cystic, which enables the injection of beta
emitters such as phosphorus-32 (32 P) radio-colloid into cysts for their treatment. The aim of …

Atualização terapêutica no tratamento dos craniofaringiomas

MAN Bordallo, RM Ferreira, DA Bulzico - Arquivos Brasileiros de …, 2011 - SciELO Brasil
O craniofaringioma é uma neoplasia de natureza benigna, pouco frequente, responsável
por 1% a 3% de todos os tumores intracranianos, sendo a mais frequente neoplasia …

Monte Carlo and analytical calculations of dose distributions in craniopharyngioma cysts treated with radiocolloids containing 32P or 186Re

M Sadeghi, E Karimi, D Sardari - Applied Radiation and Isotopes, 2009 - Elsevier
In radiation treatments of some types of brain tumors, such as craniopharyngiomas,
selection of an appropriate radionuclide is critical. The aim of this work was to calculate …